Production of vaccines for treatment of infectious diseases by transgenic plants

Since the first pathogen antigen was expressed in transgenic plants with the aim of producing edible vaccine in early 1990s, transgenic plants have become a well-established expression system for production of alternative vaccines against various human and animal infectious diseases. The main focus...

Full description

Bibliographic Details
Main Authors: Kristina LEDL, Zlata LUTHAR
Format: Article
Language:English
Published: University of Ljubljana Press (Založba Univerze v Ljubljani) 2016-04-01
Series:Acta Agriculturae Slovenica
Subjects:
Online Access:https://journals.uni-lj.si/aas/article/view/12645
_version_ 1797697984727613440
author Kristina LEDL
Zlata LUTHAR
author_facet Kristina LEDL
Zlata LUTHAR
author_sort Kristina LEDL
collection DOAJ
description Since the first pathogen antigen was expressed in transgenic plants with the aim of producing edible vaccine in early 1990s, transgenic plants have become a well-established expression system for production of alternative vaccines against various human and animal infectious diseases. The main focus of plant expression systems in the last five years has been on improving expression of well-studied antigens such as porcine reproductive and respiratory syndrome (PRRSV), bovine viral diarrhea disease virus (BVDV), footh and mouth disease virus (FMDV), hepatitis B surface antigen (HBsAg), rabies G protein, rotavirus, Newcastle disease virus (NDV), Norwalk virus capsid protein (NVCP), avian influenza virus H5N1, Escherichia coli heat-labile enterotoxin subunit B (LT-B), cholera toxin B (CT-B), human immunodeficiency virus (HIV), artherosclerosis, ebola and anthrax. Significant increases in expression have been obtained using improved expression vectors, different plant species and transformation methods.
first_indexed 2024-03-12T03:47:42Z
format Article
id doaj.art-a4269692444a47bdaecd41efb1c47348
institution Directory Open Access Journal
issn 1854-1941
language English
last_indexed 2024-03-12T03:47:42Z
publishDate 2016-04-01
publisher University of Ljubljana Press (Založba Univerze v Ljubljani)
record_format Article
series Acta Agriculturae Slovenica
spelling doaj.art-a4269692444a47bdaecd41efb1c473482023-09-03T12:36:04ZengUniversity of Ljubljana Press (Založba Univerze v Ljubljani)Acta Agriculturae Slovenica1854-19412016-04-01107110.14720/aas.2016.107.1.1919037Production of vaccines for treatment of infectious diseases by transgenic plantsKristina LEDL0Zlata LUTHAR1Biotechnical Faculty, University of Ljubljana, Jamnikarjeva 101, SI-1000 LjubljanaBiotechnical Faculty, University of Ljubljana, Jamnikarjeva 101, SI-1000 Ljubljana Since the first pathogen antigen was expressed in transgenic plants with the aim of producing edible vaccine in early 1990s, transgenic plants have become a well-established expression system for production of alternative vaccines against various human and animal infectious diseases. The main focus of plant expression systems in the last five years has been on improving expression of well-studied antigens such as porcine reproductive and respiratory syndrome (PRRSV), bovine viral diarrhea disease virus (BVDV), footh and mouth disease virus (FMDV), hepatitis B surface antigen (HBsAg), rabies G protein, rotavirus, Newcastle disease virus (NDV), Norwalk virus capsid protein (NVCP), avian influenza virus H5N1, Escherichia coli heat-labile enterotoxin subunit B (LT-B), cholera toxin B (CT-B), human immunodeficiency virus (HIV), artherosclerosis, ebola and anthrax. Significant increases in expression have been obtained using improved expression vectors, different plant species and transformation methods. https://journals.uni-lj.si/aas/article/view/12645transgenic plantsvaccine productionrecombinant proteinsantibodiesinfectious diseasesrisk assessment
spellingShingle Kristina LEDL
Zlata LUTHAR
Production of vaccines for treatment of infectious diseases by transgenic plants
Acta Agriculturae Slovenica
transgenic plants
vaccine production
recombinant proteins
antibodies
infectious diseases
risk assessment
title Production of vaccines for treatment of infectious diseases by transgenic plants
title_full Production of vaccines for treatment of infectious diseases by transgenic plants
title_fullStr Production of vaccines for treatment of infectious diseases by transgenic plants
title_full_unstemmed Production of vaccines for treatment of infectious diseases by transgenic plants
title_short Production of vaccines for treatment of infectious diseases by transgenic plants
title_sort production of vaccines for treatment of infectious diseases by transgenic plants
topic transgenic plants
vaccine production
recombinant proteins
antibodies
infectious diseases
risk assessment
url https://journals.uni-lj.si/aas/article/view/12645
work_keys_str_mv AT kristinaledl productionofvaccinesfortreatmentofinfectiousdiseasesbytransgenicplants
AT zlataluthar productionofvaccinesfortreatmentofinfectiousdiseasesbytransgenicplants